Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | GSK3A | P49840 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4080149 | 1.00 | GAA (0.47) | GAAMEN1KMT2AGSK3BPRKCA | |
| Hydrochloric Acid SCHEMBL27504935 | 0.98 | LMNA (0.47) | GAAMEN1KMT2AGSK3BPRKCA | |
| SCHEMBL65358 | 0.98 | ALDH1A1 (0.46) | GAAMEN1KMT2AGSK3BPRKCA | |
| SCHEMBL29419289 | 0.96 | ALDH1A1 (0.45) | GAAMEN1KMT2AGSK3BPRKCA | |
| Bromide SCHEMBL18396974 | 0.96 | ALDH1A1 (0.45) | GAAMEN1KMT2AGSK3BPRKCA | |
| Hydrochloric Acid SCHEMBL28944198 | 0.96 | LMNA (0.49) | GAAMEN1KMT2AGSK3BPRKCA | |
| SCHEMBL11116362 | 0.94 | LMNA (0.46) | GAAMEN1KMT2AGSK3BPRKCA | |
| SCHEMBL689078 | 0.92 | LMNA (0.45) | GAAMEN1KMT2AGSK3BALDH1A1 | |
| Piperidine SCHEMBL28688762 | 0.89 | SIGMAR1 (0.43) | GAAMEN1KMT2AGSK3BPRKCA | |
| SCHEMBL2373233 | 0.89 | MGAM (0.50) | GAAGSK3BALDH1A1LMNAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116315083-B | Nonaqueous electrolyte and lithium ion battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2023116005-A1 | NONAQUEOUS ELECTROLYTE AND LITHIUM ION BATTERY CONTAINING SAME | 张家港市国泰华荣化工新材料有限公司 | 2023-06-29 | — | — | WO | claimed |
| CN-116315083-A | Nonaqueous electrolyte and lithium ion battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-117845051-B | Temperature-control type hydrophobic extractant for homogeneously separating gold (III), preparation method thereof and extraction method thereof | 山东大学 | 2026-04-10 | — | — | CN | disclosed |
| US-20260076982-A1 | Prodrugs of Cannbidiol [CBD]-Type Phytocannabinoids and a Process for Preparation Thereof | COUNCIL SCIENT IND RES (IN) | 2026-03-19 | — | — | US | disclosed |
| EP-4551241-A1 | PRODRUGS OF CANNBIDIOL [CBD]-TYPE PHYTOCANNABINOIDS AND A PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2025-05-14 | — | — | EP | disclosed |
| CN-117845051-A | Temperature-control type hydrophobic extractant for homogeneously separating gold (III), preparation method thereof and extraction method thereof | 山东大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-117845051-A | Temperature-control type hydrophobic extractant for homogeneously separating gold (III), preparation method thereof and extraction method thereof | 山东大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-116315083-B | Nonaqueous electrolyte and lithium ion battery containing same | 张家港市国泰华荣化工新材料有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024041519-A1 | MORPHOLINYL QUINAZOLINE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 上海璎黎药业有限公司 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024009324-A1 | PRODRUGS OF CANNBIDIOL [CBD]-TYPE PHYTOCANNABINOIDS AND A PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-01-11 | — | — | WO | disclosed |
| WO-1995032184-A1 | SYSTEMATIC MODULAR PRODUCTION OF AMINIMIDE- AND OXAZOLONE- BASED MOLECULES HAVING AT LEAST TWO STRUCTURAL DIVERSITY ELEMENTS | ARQULE, INC. (US) | 1995-11-30 | — | — | WO | disclosed |
| US-5294623-A | (Benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma | SANKYO COMPANY, LIMITED (JP) | 1994-03-15 | — | — | US | disclosed |
| EP-0470686-A2 | (Benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma | Sankyo Company Limited (JP) | 1992-02-12 | — | — | EP | disclosed |
| US-4399146-A | Treatment of atherosclerosis with khellin-related furochromones | THE UPJOHN COMPANY (US) | 1983-08-16 | — | — | US | disclosed |
| US-4313881-A | 5-Hydroxyfurochromones | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4313882-A | 7-Methyl-6-methylthio-, methylsulfinyl-, and methylsulfonyl-methyl-furochromones | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4313883-A | ANTHIATHEROSCLEROSIS | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4304722-A | Benzo[1,2-b:5,4-b']difuran-3(2H)-ones | THE UPJOHN COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| US-4284569-A | Antiatherosclerotic furochromones | THE UPJOHN COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076982-A1 | Prodrugs of Cannbidiol [CBD]-Type Phytocannabinoids and a Process for Preparation Thereof | CNR1, CNR2, CBR1 | GAA 3664/4885MEN1 4499/4885KMT2A 3280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.